MOEXA
Live / Applied — New application — not yet assigned to an examiner (as of 30 Dec 2025)
What this means for you
Not registered yet, but its 30 Dec 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99572306
- Mark type
- Stylized text
- Filed
- 30 Dec 2025
- Attorney of record
- Joseph G. Chu
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cancer and fibrosis; Pharmaceutical preparations for medical purposes; Medical preparations for the treatment of cancer and fibrosis; Veterinary pharmaceutical preparations for the treatment of cancer and fibrosis; Medicaments for the treatment and prevention of cancer and fibrosis; Anti-cancer preparations; Medicaments for the treatment of cancer; Diagnostic agents, preparations and substances for medical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Chemical preparations for pharmaceutical or medical purposes, namely, for preparations of therapeutic compounds for treatment, inhibition or prevention of cell proliferation, preparations and medicaments for therapeutic compounds for treatment, inhibition or prevention of cancer and fibrosis; Veterinary pharmaceutical preparations for the prevention of cancer and fibrosis; Pharmaceutical preparations for the prevention of cell proliferation; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the prevention of fibrosis; Medicaments for the prevention of fibrosis; Dietetic foods adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic pet foods adapted for veterinary use; Dietetic pet foods adapted for veterinary purposes; Dietary supplements for humans and animals; Pharmaceutical preparations for preparation of therapeutic compounds for treatment, inhibition or prevention of cancer and fibrosis; Medicaments for preparation of therapeutic compounds for treatment, inhibition or prevention of cancer and fibrosis; Medicaments for the prevention of cell proliferation; Medicaments for the prevention of cancer
Owner
- Moexa Pharmaceuticals Limited, Shek Mun, HK
Prosecution history
- 30 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 30 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 30 Dec 2025 — NEW APPLICATION ENTERED